Development of bifunctional vaginal suppositories by joint use terconazole and probiotic for treatment and prophylaxis of vulvovaginal candidiasis

References

• Sobel J. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961–1971.
   PubMed Web of Science ®Google Scholar
• Sobel J, Chaim W. Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol. 1996; 34(10):2497–2499.
   PubMed Web of Science ®Google Scholar
• Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014;289(3):479–489.
   PubMed Web of Science ®Google Scholar
• Dover SE, Aroutcheva AA, Faro S, et al. Natural antimicrobials and their role in vaginal health: a short review. Int J Probiotics Prebiotics. 2008; 3(4):219–230.
   PubMedGoogle Scholar
• Uehara S, Monden K, Nomoto K, et al. A pilot study evaluating the safety and effectiveness of lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents . 2006; 28:30–34.
   PubMed Web of Science ®Google Scholar
• Slaver CM. Lactobacillus: a review. Clin. Microbiol Newsletter. 2008; 30:23–27.
   Google Scholar
• Klebanoff SJ, Hillier SL, Eschenbach DA, et al. Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis. 1991;164(1):94–100.
   PubMed Web of Science ®Google Scholar
• Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis. 1996;174(5):1058–1063.
   PubMed Web of Science ®Google Scholar
• Strus M, Brzychczy-Wloch M, Kucharska A, et al. Inhibitory activity of vaginal lactobacillus bacteria on yeasts causing vulvovaginal candidiasis. Med Dosw Mikrobiol. 2005;57(1):7–17.
   PubMedGoogle Scholar
• Vallor AC, Antonio MA, Hawes SE, et al. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis. 2001;184(11):1431–1433.
   PubMed Web of Science ®Google Scholar
• Heeres J, Hendrickx R, Van Cutsem J. Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal. J Med Chem. 1983;26(4):611–613.
   PubMedGoogle Scholar
• Thomason L. Clinical evaluation of terconazole. United States experience. J Reprod Med. 1989;34(8 Suppl):597–601.
   PubMedGoogle Scholar
• Slavin MB, Benrubi GI, Parker R, et al. Single dose oral fluconazole vs intravaginal terconazole in treatment of candida vaginitis. J Florida Med Assoc. 1992; 79:693–696.
   PubMedGoogle Scholar
• Anukam K, Osazuwa E, Ahonkhai I, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 2006; 8(6):1450–1454.
   PubMed Web of Science ®Google Scholar
• Martinez RCR, Franceschin SA, Patta MC, et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol. 2009;48(3):269–386.
   PubMed Web of Science ®Google Scholar
• Reiko Y, Hiraku O, Yoshiharu M. Preparation and evaluation of double-phased mucoadhesive suppositories of lidocaine utilizing carbopol and white beeswax. J Controlled Release. 1999; 61:1–8.
   PubMed Web of Science ®Google Scholar
• Pashayan M. Formulation and investigation of vaginal double layer suppositories containing lactobacilli and herbal extract. N Armenian Med J. 2011; 5(2):54–59.
   Google Scholar
• Pashayan M, Hovhannisyan H. Isolation and characterization of hydrogen peroxide producing vaginal lactobacilli. J Microb Epidemiol Immunobiol. 2011; 6:90–93.
   Google Scholar
• Margareth RC, Raimar L, May A. Simulated biological fluids with possible application in dissolution testing. Dissolut Technol. 2011;18(3):15–28.
   Web of Science ®Google Scholar
• Hovhannisyan Hg Grigoryan GG. Evolution of adhesive and aggregative properties of lactic acid bacteria, isolated from healthy Armenian women vagina. Int J Med Pharm Sci. 2015; 6(3):1–4.
   Google Scholar
• Allen L. Quality control of suppositories. Suppositories. 1st ed. UK: The Pharmaceutical Press; 2008. p. 39–58.
   Google Scholar
• Srilakshmi M, Renuka Devi GN, Sharmila S, et al. Spectrophotometric determination water soluble drug terconazole using hydrotropic solubilization technique. Indo Am J Pharm Res. 2013; 3(5):3527–3534.
   Google Scholar
• God SC. Pharmaceutical manufacturing handbook. New Jersey (NJ): Wiley-Interscience; 2008. p. 811–815.
   Google Scholar
• Falagas M, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother. 2006; 58(2):266–272.
   PubMed Web of Science ®Google Scholar
• Osset J, García E, Bartolomé RM, et al. Role of lactobacillus as protector against vaginal candidiasis. Med Clin. 2001;117(8):285–288.
   PubMed Web of Science ®Google Scholar
• Verdenelli M, Coman M, Cecchini C, et al. Evaluation of antipathogenic activity and adherence properties of human lactobacillus strains for vaginal formulations. J Appl Microbiol. 2014; 116(5):1297–1307.
   PubMed Web of Science ®Google Scholar
• Ferreira C, Pereira A, Pereira M, et al. Biofilm control with new microparticles with immobilized biocide. J Heat Transfer Eng. 2013; 34(8-9):712–718.
   Web of Science ®Google Scholar
• Todorov SD, Botes M, Danova ST, et al. Probiotic properties of Lactococcus lactis ssp. lactis HV219, isolated from human vaginal secretions. J Appl Microbiol. 2007;103(3):629–639.
   PubMed Web of Science ®Google Scholar
• Nader-Macías MEF, Silva de Ruiz C, Ocaña VS, et al. Advances in the knowledge and clinical applications of lactic acid bacteria as probiotics in the urogenital tract. Curr Womens Health Rev. 2008;4(4):240–257.
   Google Scholar
• Osset J, Bartolome RM, Garcıa E, et al. Assessment of the capacity of lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis. 2001;183(3):485–491.
   PubMed Web of Science ®Google Scholar
• Boris S, Suárez JE, Barbés C. Characterization of the aggregation promoting factor from Lactobacillus gasseri, a vaginal isolate. J Appl Microbiol. 1997;83(4):413–420.
   PubMed Web of Science ®Google Scholar
• Goodarzi A, Hovhannisyan H, Barseghyan A. The use of str mutations for enhancement of hydrogen peroxide formation by Lactobacillus delbrueckii MH-10 at refrigeration conditions. J Food Sci Eng. 2016; 6:90–97.
   Google Scholar
• Tanaka M, Kuwahara E, Takahashi M, et al. Enhanced rectal absorption of amphotericin B lyophilized with glycyrrhizinate in rabbits. Biol Pharm Bull. 1998;21(8):853–857.
   PubMed Web of Science ®Google Scholar
• Kaewnopparat S, Kaewnopparat N. Formulation and evaluation of vaginal suppositories containing lactobacillus. Int J Med Health Biomed Bioeng Pharm Eng. 2009; 3(7):117–120.
   Google Scholar
• Yahagi R, Machida Y, Onishi H, et al. Mucoadhesive suppositories of ramosetron hydrochloride utilizing carbopol®. Int J Pharm. 2000;193(2):205–212.
   PubMedGoogle Scholar
• Hiorth M, Nilsen S, Tho I. Bioadhesive mini-tablets for vaginal drug delivery. Pharmaceutics. 2014; 6(3):494–511.
   PubMedGoogle Scholar
• Mirmonsef P, Modur S, Burgad D, et al. An exploratory comparison of vaginal glycogen and lactobacillus levels in pre- and post-menopausal women. Menopause. 2015; 22(7):702–709.
   PubMed Web of Science ®Google Scholar
• Rodrigues F, Maia MJ, Neves J, et al. Vaginal suppositories containing Lactobacillus acidophilus: development and characterization. Drug Dev Ind Pharm. 2015;41(9):1518–1525.
   PubMed Web of Science ®Google Scholar
• Tachedjian G, O'Hanlon DE, Ravel J. The implausible “in vivo” role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota. Microbiome. 2018;6(1):29–25.
   PubMedGoogle Scholar